VA Ketamine Treatment: Coverage and Access for Veterans

The VA does provide access to ketamine-based treatment for some veterans, primarily through esketamine (Spravato), an FDA-approved nasal spray for treatment-resistant depression and depression with suicidal thoughts. Coverage is not automatic: it generally requires a diagnosis of treatment-resistant depression, documented failure of other antidepressants, and approval through the VA's formulary review process. Intravenous (IV) ketamine, which is used off-label, is offered at a smaller number of VA facilities and is less consistently available. This article explains how access actually works, who may qualify, and what veterans can do if the VA route is not available to them.

How VA ketamine treatment access works

VA ketamine treatment falls into two broad categories, and the difference matters for coverage. The first is esketamine (brand name Spravato), which the FDA approved for treatment-resistant depression in 2019. Because it is FDA-approved, it can be added to a veteran's care through the VA pharmacy benefit when clinical criteria are met. The second is racemic IV ketamine, which is used off-label for depression and certain pain conditions. Off-label use is legal and supported by a growing body of research, but it is funded and offered at the discretion of individual VA medical centers rather than guaranteed system-wide.

Veterans typically reach these treatments through a referral from a VA mental health provider after standard treatments have not provided adequate relief. Spravato must be administered in a certified healthcare setting with monitoring, so the VA delivers it through specialized clinics rather than at home.

Who may be eligible

Eligibility is driven by clinical need, not simply by veteran status. A provider generally looks for:

• A diagnosis of major depressive disorder, often described as treatment-resistant
• Inadequate response to two or more antidepressants taken at an adequate dose and duration
• For some indications, current suicidal ideation requiring rapid intervention
• No medical contraindications, which the care team screens for before approval

Studies suggest ketamine and esketamine can produce relatively rapid reductions in depressive symptoms for people who have not responded to conventional medications. They are not described in the research as cures, and benefits often require maintenance treatment to be sustained.

What VA coverage typically includes

When a veteran qualifies for Spravato through the VA, the medication, administration, and required monitoring are generally covered as part of VA healthcare, subject to the same copay rules that apply to other VA mental health and pharmacy services. Many veterans pay little or nothing depending on their priority group, service-connected status, and income. Because off-label IV ketamine is not standardized across the system, coverage for it varies by facility and should be confirmed directly with your VA care team.

Treatment	FDA status	VA availability
Esketamine (Spravato)	FDA-approved for treatment-resistant depression	Available through VA pharmacy benefit when criteria are met
IV ketamine	Off-label for depression	Offered at select VA facilities; varies locally

Steps for veterans to pursue treatment

1. Talk with your VA primary care or mental health provider about your treatment history and current symptoms.
2. Ask specifically whether Spravato or ketamine is appropriate and available at your VA medical center or through a community care referral.
3. Request a referral to a VA mental health specialist if one is not already in place.
4. Review costs, copays, and scheduling, including the time commitment for monitored sessions.

If the VA cannot offer the treatment locally, the Veterans Community Care Program may, in some cases, authorize care from a non-VA provider when access standards are not met. This requires VA authorization in advance, so coordinate it through your care team rather than booking independently and expecting reimbursement.

If the VA route does not work out

Some veterans choose private clinics for IV ketamine, which is frequently paid out of pocket because commercial insurers and the VA do not reliably cover off-label infusions. If you are weighing this, it helps to understand the differences between treatment formats and settings. Our guides on cost and insurance and comparing treatment options can help you frame questions before committing. When evaluating a clinic, our resource on choosing a provider outlines credentials and safety practices to look for, and the safety hub covers screening and monitoring expectations.

Whatever path you consider, keep your VA mental health team informed. Coordinating care reduces the risk of medication interactions and ensures someone is tracking your overall treatment plan.

This article is patient education and not medical advice. Decisions about ketamine treatment should be made with a qualified clinician who knows your full medical history.

Frequently Asked Questions

Does the VA pay for ketamine treatment?

The VA can cover esketamine (Spravato) for treatment-resistant depression when clinical criteria are met, subject to standard VA copay rules. Off-label IV ketamine is offered at some facilities but coverage varies, so confirm with your VA care team.

How do veterans qualify for ketamine or Spravato through the VA?

Eligibility is based on clinical need, typically a depression diagnosis with inadequate response to two or more antidepressants. A VA mental health provider evaluates your history and screens for contraindications before approval.

Can veterans get ketamine from a non-VA clinic and have the VA pay?

Sometimes, through the Veterans Community Care Program when VA access standards aren't met, but it requires advance VA authorization. Coordinate this with your care team rather than booking independently.

Is ketamine a cure for PTSD or depression?

No. Research suggests ketamine and esketamine can rapidly reduce depressive symptoms for some people, but they are not described as cures and often require maintenance treatment to sustain benefits.